• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Cardiovascular therapeutics >Nutraceuticals in the early infancy.
【24h】

Nutraceuticals in the early infancy.

机译：婴儿早期的保健食品。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Atherosclerosis disease and its extent in childhood correlate positively with established risk factors, namely obesity, hypercholesterolemia, diabetes mellitus, and hypertension. The safety and efficacy of some dietary interventions to modulate risk factors in childhood are documented by an increasing body of evidence. The present review analyzes nutritional and nutraceutical current strategies addressed to modify some risk factors of atherosclerosis in childhood. In particular, studies concerning nutrients such as fibers, omega-3-fatty acids, vitamin D, antioxidants, and calcium have been evaluated. An overall analysis suggests that some nutraceuticals might represent an attractive tool to lower the development of atherosclerotic-related cardiovascular complication in children. Nevertheless, at this moment, due to the methodological weakness that characterizes the majority of the analyzed studies, nutrients or supplements should not be considered as a therapeutic tool potentially usable for clinical purpose in children at risk for cardiovascular disease.
机译：动脉粥样硬化疾病及其在儿童时期的程度与确定的危险因素呈正相关，即肥胖，高胆固醇血症，糖尿病和高血压。越来越多的证据证明了一些饮食干预措施可以调节儿童期的危险因素的安全性和有效性。本综述分析了目前的营养和营养保健策略，以解决儿童期动脉粥样硬化的一些危险因素。尤其是，已经评估了有关营养素的研究，例如纤维，omega-3-脂肪酸，维生素D，抗氧化剂和钙。总体分析表明，某些营养保健品可能是降低儿童动脉粥样硬化相关心血管并发症发生的有吸引力的工具。然而，由于目前大多数分析研究都存在方法学上的缺陷，因此目前不应将营养素或补品视为具有心血管疾病风险的儿童可用于临床的治疗工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号